Summit Therapeutics Inc. (SMMT) earnings date
Feb 22, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 33 days, typically, give or take 13 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Wed, Nov 4, 2026 | after close | 35 | 8-K |
| Q2 FY2026 | Thu, Jul 23, 2026 | after close | 23 | 8-K |
| Q1 FY2026 | Thu, Apr 30, 2026 | after close | 30 | 8-K |
| Q4 FY2025 | Mon, Feb 23, 2026 | after close | 54 | 8-K |
| Q3 FY2025 | Mon, Oct 20, 2025 | before open | 20 | 8-K |
| Q2 FY2025 | Mon, Aug 11, 2025 | after close | 42 | 8-K |
| Q1 FY2025 | Thu, May 1, 2025 | after close | 31 | 8-K |
| Q4 FY2024 | Mon, Feb 24, 2025 | before open | 55 | 8-K |
What they guided beta
| Q3 FY2026 | "The number of PFS events needed in the squamous cohort for the primary analysis is expected to be reached in the fourth quarter of 2026, and a planned early interim analysis for OS is expected to take place in conjunction with the primary PFS analysis." exhibit |
| Q3 FY2026 | "For the non-squamous cohort, the number of events needed to conduct the PFS analysis is expected to be reached in the first half of 2027." exhibit |
| Q3 FY2026 | "Summit's global Phase III HARMONi-7 trial continues to enroll, with enrollment expected to be completed in 2027." exhibit |
| Q3 FY2026 | "The enrollment rate has exceeded initial estimations and is currently expected to complete in Q3 2027." exhibit |
| Q3 FY2026 | "In September 2026, Summit entered into a clinical trial collaboration with AstraZeneca to evaluate ivonescimab in combination with AstraZeneca’s Claudin 18.2-targeting ADC, sonesitatug vedotin, also referred to as sone- ve, in certain gastrointestinal cancer settings." exhibit |
| Q2 FY2026 | "HARMONi-3 Global Phase III 1L NSCLC Study: Squamous Cohort Final PFS Analysis Events Expected to Be Reached in Second Half of 2026 with Interim OS Analyses Planned; Non-Squamous Cohort PFS Events Expected to Be Reached in the First Half of 2027" exhibit |
| Q2 FY2026 | "The number of PFS events needed in the squamous cohort for the primary analysis is expected to be reached in the second half of 2026, and a planned early interim analysis for OS is expected to take place" exhibit |
| Q2 FY2026 | "For the non-squamous cohort, the number of events needed to conduct the PFS analysis is expected to be reached in the first half of 2027." exhibit |
| Q2 FY2026 | "Data from the study under this collaboration agreement is expected to be generated by mid-2027." exhibit |
| Q2 FY2026 | "During the second quarter of 2026, the company raised $230.8 million in gross proceeds through its ATM facility." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/SMMT
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/SMMT
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/SMMT/"><img src="https://veritasdata.dev/embed/SMMT.svg" alt="SMMT earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/SMMT/)
Script
<script async src="https://veritasdata.dev/embed/SMMT.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/SMMT"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.